Search Results - "CROGHAN, T. W"

Refine Results
  1. 1

    Racial variation in antidepressant treatment in a Medicaid population by MELFI, C. A, CROGHAN, T. W, HANNA, M. P, ROBINSON, R. L

    Published in The journal of clinical psychiatry (01-01-2000)
    “…Many studies have found racial and socioeconomic variation in medical care for a variety of conditions. Undertreatment of depression for individuals of all…”
    Get full text
    Journal Article
  2. 2

    The controversy of increased spending for antidepressants by Croghan, T W

    Published in Health Affairs (01-03-2001)
    “…Antidepressant medications provide an excellent case study of the broader issue of drug spending. Persons with depressive disorders represent a large,…”
    Get full text
    Journal Article
  3. 3

    Determinants of antidepressant treatment outcome by Sood, N, Treglia, M, Obenchain, R L, Dulisse, B, Melfi, C A, Croghan, T W

    Published in The American journal of managed care (01-12-2000)
    “…To understand the determinants of the outcome of an episode of major depression, including factors that affect receipt of guideline-consistent care and their…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Effect of antidepressant therapy on health care utilization and costs in primary care by CROGHAN, T. W, LAIR, T. J, ENGELHART, L, CROWN, W. E, COPLEY-MERRIMAN, C, MELFI, C. A, OBENCHAIN, R. L, BUESCHING, D. P

    Published in Psychiatric services (Washington, D.C.) (01-11-1997)
    “…OBJECTIVE: Four groups of patients receiving different antidepressant drugs in a primary care setting were compared in terms of duration of antidepressant…”
    Get full text
    Journal Article
  6. 6

    Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence by DiMatteo, M R, Lepper, H S, Croghan, T W

    Published in Archives of internal medicine (1960) (24-07-2000)
    “…Depression and anxiety are common in medical patients and are associated with diminished health status and increased health care utilization. This article…”
    Get more information
    Journal Article
  7. 7

    Impact of pain on depression treatment response in primary care by Bair, Matthew J, Robinson, Rebecca L, Eckert, George J, Stang, Paul E, Croghan, Thomas W, Kroenke, Kurt

    Published in Psychosomatic medicine (01-01-2004)
    “…Pain commonly coexists with depression, but its impact on treatment outcomes has not been well studied. Therefore, we prospectively evaluated the impact of…”
    Get full text
    Journal Article
  8. 8

    Routes to Better Health for Children in Four Developing Countries by CROGHAN, THOMAS W., BEATTY, AMANDA, RON, AVIVA

    Published in The Milbank quarterly (01-01-2006)
    “…Despite the availability of effective, affordable interventions for the most common causes of death, more than ten million children in developing countries die…”
    Get full text
    Journal Article
  9. 9

    Economic consequences of selective serotonin reuptake inhibitor use with drugs also metabolized by the cytochrome P-450 system by Ozminkowski, Ronald J., Hylan, Timothy R., Melfi, Catherine A., Meneades, Laurie M., Crown, William H., Croghan, Thomas W., Robinson, Rebecca L.

    Published in Clinical therapeutics (01-07-1998)
    “…Administration of selective serotonin reuptake inhibitors (SSRIs) may increase plasma concentrations of concomitant medications that are also metabolized by…”
    Get full text
    Journal Article
  10. 10

    The Effects of Adherence to Antidepressant Treatment Guidelines on Relapse and Recurrence of Depression by Melfi, Catherine A, Chawla, Anita J, Croghan, Thomas W, Hanna, Mark P, Kennedy, Sean, Sredl, Kate

    Published in Archives of general psychiatry (01-12-1998)
    “…BACKGROUND Depression is associated with high rates of relapse and recurrence during a patient's lifetime. Current guidelines regarding treatment recommend 4…”
    Get full text
    Journal Article
  11. 11

    Reliability, Validity, and Application of the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) in Schizophrenic Patients Treated with Olanzapine versus Haloperidol by Tunis, Sandra L., Croghan, Thomas W., Heilman, Douglas K., Johnstone, Bryan M., Obenchain, Robert L.

    Published in Medical care (01-07-1999)
    “…Schizophrenia leads to impairments in mental, social, and physical functioning, which should be included in evaluations of treatment. Objectives. This study…”
    Get full text
    Journal Article
  12. 12

    Provider type and depression treatment adequacy by Kniesner, Thomas J., Powers, Regina H., Croghan, Thomas W.

    Published in Health policy (Amsterdam) (01-06-2005)
    “…We investigate the effect of initial provider (psychiatrist versus primary care physician or non-physician mental health specialist) on the adequacy of…”
    Get full text
    Journal Article
  13. 13

    Use of Claims Data for Research on Treatment and Outcomes of Depression Care by Melfi, Catherine A., Croghan, Thomas W.

    Published in Medical care (01-04-1999)
    “…Background. Data sources such as medical insurance claims are increasingly used in outcomes research. In this report, we present opportunities and limitations…”
    Get full text
    Journal Article
  14. 14

    Determinants of Antidepressant Treatment Compliance: Implications for Policy by Tai-Seale, Ming, Croghan, Thomas W., Obenchain, Robert

    Published in Medical care research and review (01-12-2000)
    “…Depression is among the most prevalent, devastating, and undertreated disorders in our society. Treatment with antidepressant medications is effective in…”
    Get full text
    Journal Article
  15. 15

    Does the Americans with Disabilities Act accommodate depressed workers? by Croghan, T W, Kniesner, T J, Powers, R H

    Published in Health affairs (Millwood, Va.) (01-09-1999)
    “…A study concludes that, as it is now applied, the Americans with Disabilities Act only partially accommodates the needs of mentally depressed workers. On the…”
    Get full text
    Journal Article
  16. 16

    What does treatment of depression really cost? by Croghan, T W, Obenchain, R L, Crown, W E

    Published in Health Affairs (01-07-1998)
    “…This DataWatch presents estimates of the health care charges for adults who are diagnosed and treated for depression in primary care. More than nine out of ten…”
    Get full text
    Journal Article
  17. 17

    Effect of Mental Health Specialty Care on Antidepressant Length of Therapy by Croghan, Thomas W., Melfi, Catherine A., Dobrez, Deborah G., Kniesner, Thomas J.

    Published in Medical care (01-04-1999)
    “…Objectives. Treatment of depression with medications and psychotherapy clearly is efficacious, but not all patients require such intensive therapy. In this…”
    Get full text
    Journal Article
  18. 18

    SSRI Antidepressant Drug Use Patterns in the Naturalistic Setting: A Multivariate Analysis by Hylan, Timothy R., Crown, William H., Meneades, Laurie, Heiligenstein, John H., Melfi, Catherine A., Croghan, Thomas W., Buesching, Don P.

    Published in Medical care (01-04-1999)
    “…Background. The study of the duration and pattern of antidepressant use in actual clinical practice can provide important insights into how antidepressant…”
    Get full text
    Journal Article
  19. 19

    Access to treatment for depression in a Medicaid population by Melfi, C A, Croghan, T W, Hanna, M P

    “…Mentally ill Medicaid recipients represent a population that may be vulnerable to limited access to adequate treatment for their mental illness. In this study,…”
    Get more information
    Journal Article
  20. 20

    Clonal analysis of peripheral T cell precursors in lpr mice by Croghan, T W, Rapaport, R, Frelinger, J S, Eisenberg, R A, Cohen, P L

    Published in Autoimmunity (Chur, Switzerland) (1992)
    “…MRL/Mp-lpr/lpr mice develop massive lymphadenopathy characterized by expansion of an unusual population of T cells with the Thy 1+, CD3+, CD4-, CD8- (double…”
    Get more information
    Journal Article